# South Korea Gamma Knife Market > South Korea Gamma Knife Market Research Report: Size, Share, Trend Analysis By Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others) and By Anatomy (Head, Neck, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.72% - **2024:** $ 13.94 Million - **2025:** $ 14.6 Million - **2035:** $ 23.16 Million - **Key Players:** Elekta AB (SE), Accuray Incorporated (US), Varian Medical Systems (US), Brainlab AG (DE), MediTech (US), Shenzhen Huikang Medical Technology Co., Ltd. (CN), Nicolet Biomedical (US), Stereotactic Radiosurgery (US) **Report ID:** MRFR/HC/50651-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-gamma-knife-market-52409 --- ## Market Summary ## **South Korea Gamma Knife Market Overview** As per MRFR analysis, the South Korea Gamma Knife Market Size was estimated at 13.31 (USD Million) in 2024.The South Korea Gamma Knife Market Industry is expected to grow from 14(USD Million) in 2025 to 35 (USD Million) by 2035. The South Korea Gamma Knife Market CAGR (growth rate) is expected to be around 8.687% during the forecast period (2025 - 2035) ## **Key South Korea Gamma Knife Market Trends Highlighted** In the South Korea Gamma Knife Market, advancements in radiotherapy technology are notable trends. The integration of sophisticated imaging techniques, such as MRI and CT scans, enhances the precision of Gamma Knife treatments. This technological evolution supports the growing preference for non-invasive treatment options among patients with brain tumors and other neurological conditions. Additionally, the increase in cancer prevalence in South Korea, driven by an aging population and lifestyle-related factors, fuels demand for effective treatment solutions like Gamma Knife radiosurgery.  Key market drivers include the strong governmental support for health technology advancements, which is reflected in initiatives aimed at improving cancer treatment facilities and access to cutting-edge therapeutic technologies.The South Korean government actively invests in healthcare infrastructure and research programs, fostering a conducive environment for the growth of the Gamma Knife market.  Moreover, the rising awareness of neurological disorders among the population is leading to a higher number of patients seeking advanced treatment methods. Opportunities to be explored involve the expansion of Gamma Knife facilities in rural and underserved areas, ensuring that more patients have access to this innovative treatment.  Collaborations between healthcare providers and research institutions also present avenues for further technological refinement and training programs for medical professionals.Recent trends point towards an increase in clinical trials focusing on the efficacy of Gamma Knife treatments, which may lead to expanded applications beyond traditional uses. Overall, the South Korea Gamma Knife Market is evolving with a focus on both technological advancement and increasing accessibility, creating a dynamic landscape in the healthcare sector. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South Korea Gamma Knife Market Drivers** **Increasing Prevalence of Brain Tumors** The prevalence of brain tumors in South Korea has been steadily increasing, contributing significantly to the growth of the South Korea Gamma Knife Market Industry. According to the Korean National Cancer Center, there has been a reported increase of approximately 3% annually in the number of brain tumor cases over the last five years. This trend emphasizes the need for advanced treatment options, such as Gamma Knife surgery offers precise and non-invasive procedures for tumor removal. In South Korea, the combined work of healthcare institutions such as the Korean Neuro-Oncology Society, which focuses on creating public awareness on the treatment of brain tumors, also increases the demand for Gamma Knife Technologies. **Technological Advancements in Gamma Knife Systems** The South Korea Gamma Knife Market Industry is significantly influenced by the rapid advancements in Gamma Knife technology. Innovative systems are being developed that offer enhanced precision and improved patient outcomes. For instance, newer models allow for adaptive planning and real-time imaging, which boosts the accuracy of tumor targeting.  The Ministry of Health and Welfare in South Korea has been keen on promoting these advancements to improve cancer treatment facilities, enabling healthcare providers to adopt cutting-edge technology, thus enhancing the overall landscape of the Gamma Knife market. **Government Initiatives and Funding for Cancer Treatment** The South Korean government has been proactive in funding and promoting cancer treatment initiatives, which is propelling the Gamma Knife market forward. The healthcare budget for cancer treatment was increased by 20% in the last fiscal year, according to the Health Insurance Review and Assessment Service.  Such government support plays a crucial role in facilitating the adoption of advanced technologies like Gamma Knife, enabling hospitals to upgrade their equipment, thereby meeting demand.This also includes collaborations with organizations such as the Korean Society for Therapeutic Radiology and Oncology, working towards better cancer care methodologies. **Rising Awareness and Acceptance of Stereotactic Radiosurgery** Public awareness and acceptance of stereotactic radiosurgery, including Gamma Knife procedures, are key factors driving growth in the South Korea Gamma Knife Market Industry. Recent campaigns by the Korea Brain Tumor Foundation focusing on patient education about the benefits of non-invasive treatment options have seen an increase in patient inquiries by approximately 30% over the past three years. This heightened awareness is resulting in more patients opting for Gamma Knife treatments over traditional surgical methods, further solidifying the market's expansion in South Korea. ## **South Korea Gamma Knife Market Segment Insights** ### **Gamma Knife Market Disease Indication Insights** The South Korea Gamma Knife Market is primarily driven by the need for precise and effective treatment options for various medical conditions, particularly within the Disease Indication segment. This segment encapsulates a critical array of health issues, including brain metastasis, cancer, [arteriovenous malformation](../../../reports/arteriovenous-malformation-market-5092), and trigeminal neuralgia, all of which play pivotal roles in shaping the market landscape. Brain metastasis is notably significant, as South Korea has seen an increase in cancer prevalence, leading to rising cases requiring targeted radiation therapy. The efficacy of Gamma Knife technology in treating such conditions with minimal damage to surrounding healthy tissue underscores its importance in contemporary medical treatments. Cancer, a leading health concern in South Korea, continues to catalyze advancements in radiation technologies, with healthcare facilities increasingly adopting advanced solutions like the Gamma Knife for treatment, owing to its non-invasive nature and shorter hospital stays.  Arteriovenous malformations represent another critical condition requiring precise intervention; the complexities associated with these vascular malformations make Gamma Knife radiosurgery a preferred option among clinicians. Meanwhile, trigeminal neuralgia, characterized by severe facial pain, often necessitates surgical intervention, creating a sustained demand for effective treatments like those offered by Gamma Knife procedures. Collectively, these disease indications illustrate both current needs and growth opportunities within the South Korea Gamma Knife Market, driven by advancements in technology, increased awareness among healthcare providers, and a growing patient population requiring specialized care. The robust healthcare framework in South Korea further supports innovations and implementations in this field, leading to enhanced treatment methodologies to combat these diseases effectively. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Gamma Knife Market Anatomy Insights** The South Korea Gamma Knife Market, particularly within the Anatomy segment, is witnessing notable growth driven by advancements in neurosurgical technology. This market encompasses various areas, notably Head, Neck, and Others, each playing a crucial role in delivering precise and effective treatment for conditions such as tumors and vascular malformations. The Head segment remains significant, as it addresses a majority of neuro-oncological procedures, aiding in tumor localization and treatment efficacy. The Neck segment, while less emphasized, is increasingly important for its contribution to the treatment of cervical spine disorders and other related conditions.The Others category captures diverse applications, enhancing the flexibility and scope of Gamma Knife treatments across varying anatomical considerations.  The growing aging population in South Korea, paired with rising incidences of neurological disorders, is expected to propel the demand for Gamma Knife technologies, fostering further innovation and development in treatment protocols. Additionally, government initiatives aimed at improving healthcare infrastructure and access to advanced medical technologies support the expansion of the South Korea Gamma Knife Market.Overall, the Anatomy segment, through its various classifications, reflects a dynamic landscape, responding to both clinical needs and technological advancements in the field of radiation therapy. **South Korea Gamma Knife Market Key Players and Competitive Insights** The South Korea Gamma Knife Market is characterized by a robust competitive landscape driven by advancements in healthcare technology and an increasing prevalence of neurological disorders requiring precise treatment methods. Gamma Knife therapy is renowned for its ability to non-invasively target tumors and other abnormalities in the brain with extreme accuracy. Various stakeholders in this market include medical device manufacturers, healthcare providers, and research institutions, all of whom contribute to the innovation and distribution of Gamma Knife systems. As the market evolves, competition intensifies, prompting companies to enhance their product offerings and expand their service capabilities to better meet the demands of both medical professionals and patients.  The presence of established players alongside emerging entities creates a dynamic environment marked by strategic collaborations, product launches, and technological advancements aimed at improving patient outcomes.CIVCO Radiotherapy holds a strong position in the South Korea Gamma Knife Market, recognized for its commitment to enhancing radiation therapy solutions. The company has developed a specialized line of products designed to support the effective and safe delivery of Gamma Knife treatments, reflecting its focus on technological innovation and customer needs. CIVCO Radiotherapy's strengths lie in its thorough understanding of the local market dynamics, which allows it to tailor its offerings to suit the preferences of healthcare providers in South Korea.  The company has built a reputation for reliability, exemplified by high-quality support services that accompany its products. Furthermore, its ongoing investment in research and development positions CIVCO Radiotherapy favorably to cater to the evolving requirements of practitioners seeking advanced solutions to enhance treatment efficacy and patient safety.Isodose Control has established itself as a significant player in the South Korea Gamma Knife Market by providing high-precision dosimetry solutions essential for effective radiation therapy management.  The company's key products include cutting-edge technology for dose verification and treatment planning, which are vital in optimizing Gamma Knife procedures. With a considerable foothold in the South Korean healthcare sector, Isodose Control has built strong relationships with major hospitals and clinics. Its strengths lie in its innovative approach to product development and the ability to adapt quickly to market needs. The company has made headlines with strategic mergers and acquisitions that enhance its technical capabilities and market reach.  By continuously expanding its product portfolio and integrating new technologies, Isodose Control has reinforced its position in South Korea, ensuring that its users have access to top-tier resources for successful Gamma Knife interventions. **Key Companies in the South Korea Gamma Knife Market Include** **South Korea Gamma Knife Market Industry Developments** The South Korea Gamma Knife Market is witnessing several noteworthy developments. In recent months, the market has seen advancements in technology and increased investments in healthcare infrastructure. For instance, the use of advanced imaging techniques combined with Gamma Knife treatments has become more prominent, promoting greater efficiency in targeting tumors while minimizing damage to surrounding tissues.  Additionally, companies such as Varian Medical Systems and Elekta have been actively collaborating with local hospitals to enhance treatment planning and patient care protocols. In terms of mergers and acquisitions, there have been strategic moves with to the local market.  In August 2023, Elekta announced the acquisition of a small South Korean tech firm focusing on software development for Gamma Knife systems, streamlining their operations and expanding their market presence. Furthermore, growth in valuation for major players like Accuray and Siemens Healthineers has been observed due to technological improvements, leading to increased demand for precise and effective cancer treatments in South Korea. Over the past 2-3 years, market expansion has been noticeable with a structured increase in investment from both private and public sectors, driven by the government's commitment to enhancing cancer care capabilities. ## **South Korea Gamma Knife Market Segmentation Insights** ### **Gamma Knife Market Disease Indication****Outlook** - Brain Metastasis - Cancer - Arteriovenous Malformation - Trigeminal Neuralgia - Others ### **Gamma Knife Market Anatomy****Outlook** - Head - Neck - Others ## Market Drivers ### Rising Incidence of Brain Disorders The gamma knife market in South Korea is experiencing growth due to the increasing incidence of brain disorders such as tumors and vascular malformations. According to health statistics, brain tumors account for a significant portion of cancer cases, with an estimated 10,000 new cases reported annually. This rising prevalence necessitates advanced treatment options, and gamma knife technology offers a non-invasive solution that is both effective and safe. The ability to target tumors with precision while minimizing damage to surrounding healthy tissue is a key factor driving the adoption of gamma knife procedures. As healthcare providers seek to enhance patient outcomes, the demand for gamma knife technology is likely to increase, thereby positively impacting the gamma knife market. ### Technological Innovations in Treatment Technological innovations play a crucial role in the gamma knife market in South Korea. Continuous advancements in imaging and treatment delivery systems enhance the efficacy of gamma knife procedures. For instance, the integration of MRI and CT imaging allows for more accurate tumor localization, which is essential for successful treatment outcomes. Furthermore, the development of robotic-assisted systems is streamlining the treatment process, making it more efficient and patient-friendly. As these innovations emerge, they are likely to attract more healthcare providers to adopt gamma knife technology, thereby driving growth in the gamma knife market. The potential for improved patient outcomes through these advancements is a compelling factor for both practitioners and patients. ### Investment in Healthcare Infrastructure The gamma knife market in South Korea is bolstered by substantial investments in healthcare infrastructure. The government and private sector are channeling funds into modernizing hospitals and medical facilities, which includes the acquisition of advanced medical equipment like gamma knives. Recent reports indicate that healthcare spending in South Korea is projected to reach $200 billion by 2026, with a significant portion allocated to oncology services. This investment not only enhances the availability of cutting-edge treatment options but also improves patient access to gamma knife procedures. As more facilities adopt this technology, the gamma knife market is expected to expand, catering to the growing demand for effective cancer treatments. ### Growing Focus on Minimally Invasive Procedures There is a growing focus on minimally invasive procedures within the gamma knife market in South Korea. Patients and healthcare providers alike are increasingly favoring treatment options that reduce recovery time and minimize surgical risks. Gamma knife surgery, which allows for targeted treatment without the need for traditional incisions, aligns perfectly with this trend. The market is witnessing a shift as more patients opt for non-invasive alternatives to conventional surgery. This preference is supported by clinical evidence demonstrating the effectiveness of gamma knife procedures in treating various conditions. As awareness of the benefits of minimally invasive treatments spreads, the gamma knife market is poised for continued growth. ### Aging Population and Increased Cancer Incidence The aging population in South Korea is a significant driver of the gamma knife market. As the demographic shifts towards an older age group, the incidence of age-related diseases, including various forms of cancer, is on the rise. Statistics indicate that approximately 30% of cancer cases in South Korea are diagnosed in individuals aged 65 and older. This demographic trend creates a heightened demand for effective treatment options, such as gamma knife surgery, which is known for its precision and minimal invasiveness. The gamma knife market is likely to benefit from this trend, as healthcare systems adapt to meet the needs of an aging population seeking advanced cancer treatment solutions. ## Future Outlook The [Gamma Knife Market](https://www.marketresearchfuture.com/reports/gamma-knife-market-19189) in South Korea is projected to grow at a 4.72% CAGR from 2025 to 2035, driven by technological advancements and increasing demand for non-invasive treatments. **New opportunities:** - Development of advanced imaging integration for enhanced precision in treatments. - Expansion of service contracts for maintenance and upgrades of gamma knife systems. - Partnerships with healthcare providers to establish specialized treatment centers. By 2035, the gamma knife market is expected to achieve robust growth and increased market penetration. ## Segment Insights ### By Disease Indication: Brain Metastasis (Largest) vs. Cancer (Fastest-Growing) In the South Korea gamma knife market, the disease indication segment exhibits a diverse landscape with brain metastasis holding the largest market share, reflecting its significant prevalence and the reliance on gamma knife treatments. Cancer, while not the dominant share, is recognized as the fastest-growing indication due to increasing incidence rates and advancements in treatment technologies. The growth trends for the South Korea gamma knife market are being driven by innovative treatment options and the rising awareness of minimally invasive procedures among healthcare providers and patients. As the healthcare industry continues to evolve, there is a notable increase in the adoption of gamma knife technologies for treating arteriovenous malformations and trigeminal neuralgia, which further diversifies the competitive landscape and encourages ongoing research and development. Brain Metastasis (Dominant) vs. Cancer (Emerging) In the South Korea gamma knife market, brain metastasis is characterized as the dominant segment, representing a substantial portion of the overall treatments due to its advanced status in recognition and application of gamma knife therapy. It showcases a robust portfolio of technological developments specifically tailored for treating this indication. On the other hand, cancer, as an emerging segment, is witnessing rapid growth fueled by new clinical guidelines and expanded treatment protocols. This segment encompasses various types of cancers, incorporating the latest research initiatives which aim to enhance efficacy and patient outcomes, thus propelling its acceptance among medical professionals. Overall, this contrast highlights the diversity and dynamic nature of treatment options available within these two significant disease indications. ### By Anatomy: Head (Largest) vs. Neck (Fastest-Growing) In the South Korea gamma knife market, the head segment commands the largest share due to its extensive applications in treating brain tumors and lesions, which are prevalent in the region. The neck segment follows as an emerging sector, reflecting an increasing acknowledgment of the gamma knife's efficacy for head and neck cancers. Collectively, these segments highlight a competitive landscape driven by advancements in technology and rising patient demand for non-invasive treatment options. Growth trends for the head segment remain stable, driven by the aging population and an increase in cancer incidences, particularly in neurology. Meanwhile, the neck segment is witnessing rapid growth, attributed to heightened awareness and efforts toward early diagnosis and the effectiveness of gamma knife treatments. This trend indicates a shift in focus within the market, as healthcare providers increasingly opt for innovative therapies to improve patient outcomes. Head (Dominant) vs. Neck (Emerging) The head segment represents the dominant force within the South Korea gamma knife market, benefitting from a well-established treatment protocol and a robust clinical framework that supports its usage. Healthcare facilities are equipped with advanced gamma knife technology, enhancing treatment precision and patient safety. Conversely, the neck segment is gaining traction as an emerging category, propelled by increased incidences of head and neck cancers and a growing preference for minimally invasive treatment options. This segment is characterized by ongoing research and development aimed at improving gamma knife applications, further solidifying its role in modern therapeutic approaches. Together, these segments form a crucial part of the overall market, indicating diverse treatment pathways for healthcare providers. ## Competitive Benchmarking The gamma knife market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Elekta AB (SE), Accuray Incorporated (US), and Varian Medical Systems (US) are at the forefront, each employing distinct strategies to enhance their market presence. Elekta AB (SE) focuses on technological advancements in stereotactic radiosurgery, while Accuray Incorporated (US) emphasizes personalized treatment solutions. Varian Medical Systems (US) is known for its robust integration of AI in treatment planning, which collectively fosters a dynamic competitive environment.The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of South Korea's advanced manufacturing capabilities. The collective influence of these companies suggests a competitive landscape where innovation and operational efficiency are paramount, driving growth and enhancing patient outcomes. In October Elekta AB (SE) announced a strategic partnership with a leading South Korean hospital to enhance the accessibility of its gamma knife technology. This collaboration is expected to facilitate the integration of advanced treatment protocols, thereby improving patient care and expanding Elekta's footprint in the region. Such partnerships are indicative of a broader trend towards localized solutions that cater to specific market needs. In September Accuray Incorporated (US) launched a new software update for its CyberKnife system, which includes enhanced imaging capabilities. This update is significant as it positions Accuray to better compete with traditional gamma knife systems by offering improved precision and treatment customization. The move reflects a strategic focus on technological innovation to meet the evolving demands of healthcare providers. In August Varian Medical Systems (US) unveiled a new AI-driven analytics platform designed to optimize treatment planning for gamma knife procedures. This initiative underscores Varian's commitment to integrating cutting-edge technology into its offerings, potentially setting a new standard for operational efficiency in the market. The emphasis on AI suggests a shift towards data-driven decision-making in treatment protocols. As of November current trends in the gamma knife market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their competitive edge. Looking ahead, it is likely that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technological advancements, and supply chain reliability, thereby reshaping the market landscape. ## Recent News & Developments The South Korea Gamma Knife Market is witnessing several noteworthy developments. In recent months, the market has seen advancements in technology and increased investments in healthcare infrastructure. For instance, the use of advanced imaging techniques combined with Gamma Knife treatments has become more prominent, promoting greater efficiency in targeting tumors while minimizing damage to surrounding tissues.  Additionally, companies such as Varian Medical Systems and Elekta have been actively collaborating with local hospitals to enhance treatment planning and patient care protocols. In terms of mergers and acquisitions, there have been strategic moves with to the local market.  In August 2023, Elekta announced the acquisition of a small South Korean tech firm focusing on software development for Gamma Knife systems, streamlining their operations and expanding their market presence. Furthermore, growth in valuation for major players like Accuray and Siemens Healthineers has been observed due to technological improvements, leading to increased demand for precise and effective cancer treatments in South Korea. Over the past 2-3 years, market expansion has been noticeable with a structured increase in investment from both private and public sectors, driven by the government's commitment to enhancing cancer care capabilities. ## Report Scope | MARKET SIZE 2024 | 13.94(USD Million) | | --- | --- | | MARKET SIZE 2025 | 14.6(USD Million) | | MARKET SIZE 2035 | 23.16(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.72% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Elekta AB (SE), Accuray Incorporated (US), Varian Medical Systems (US), Brainlab AG (DE), MediTech (US), Shenzhen Huikang Medical Technology Co., Ltd. (CN), Nicolet Biomedical (US), Stereotactic Radiosurgery (US) | | Segments Covered | Disease Indication, Anatomy | | Key Market Opportunities | Advancements in precision oncology drive growth in the gamma knife market. | | Key Market Dynamics | Technological advancements and regulatory support drive growth in the gamma knife market in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation of the gamma knife market in South Korea in 2024?** A: The market valuation was $13.94 Million in 2024. **Q: What is the projected market valuation for the gamma knife market in South Korea by 2035?** A: The projected valuation for 2035 is $23.16 Million. **Q: What is the expected CAGR for the gamma knife market in South Korea during the forecast period 2025 - 2035?** A: The expected CAGR is 4.72% during the forecast period 2025 - 2035. **Q: Which companies are the key players in the South Korean gamma knife market?** A: Key players include Elekta AB, Accuray Incorporated, Varian Medical Systems, and others. **Q: What segment had the highest valuation in the gamma knife market in 2024?** A: The segment for Cancer had the highest valuation at $6.5 Million. **Q: How much is the Brain Metastasis segment projected to grow by 2035?** A: The Brain Metastasis segment is projected to grow from $3.5 Million to $5.8 Million. **Q: What is the valuation range for the Trigeminal Neuralgia segment in 2024?** A: The valuation range for the Trigeminal Neuralgia segment was $2.5 Million to $4.0 Million. **Q: What anatomical area had the highest market valuation in 2024?** A: The Head anatomical area had the highest valuation at $9.25 Million. **Q: What is the projected valuation for the Others segment in the Disease Indication category by 2035?** A: The projected valuation for the Others segment is expected to reach $3.96 Million by 2035. **Q: How does the market for gamma knives in South Korea compare to other regions?** A: While specific comparisons are not provided, the growth trajectory suggests a robust market presence in South Korea. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-gamma-knife-market-52409*